Holly B. Kordasiewicz, EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC (IONS), sold 60,846 shares at $73.09 ($4.5M) on 2026-06-12, disclosed to the SEC on 2026-06-16.
Scheduled sale ($4.5M) by EVP, Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.09 | 41,004 | $3.0M | 67.1% |
| 2 | $74.05 | 19,842 | $1.5M | 32.9% |
| Total | $73.41 avg | 60,846 | $4.5M | 100% |
| Filing → |